Standards of Medical Care in Diabetes—2022 Abridged for Primary Care Providers
Open accessAbstract
American Diabetes AssociationThe American Diabetes Association's (ADA's) Standards of Medical Care in Diabetes (the Standards) is updated and published annually in a supplement to the January issue of Diabetes Care.The Standards are developed by the ADA's multidisciplinary Professional Practice Committee, which comprises expert diabetes health care professionals.The Standards include the most current evidence-based recommendations for diagnosing and treating adults and children with all forms of diabetes.ADA's grading system uses A, B, C, or E to show the evidence level that supports each recommendation.A-Clear evidence from well-conducted, generalizable randomized controlled trials that are adequately powered B-Supportive evidence from well-conducted cohort studies C-Supportive evidence from poorly controlled or uncontrolled studies E-Expert consensus or clinical experience This is an abridged version of the current Standards of Care containing the evidence-based recommendations most pertinent to primary care.The recommendations, tables, and figures included here retain the same numbering used in the complete Standards.All of the recommendations included here are substantively the same as in the complete Standards.The abridged version does not include references.The complete 2022 Standards of Care, including all supporting references, is available at professional.diabetes.org/standards.*After the onset of puberty or after 10 years of age, whichever occurs earlier.If tests are normal, repeat testing at a minimum of 3-year intervals, or more frequently if BMI is increasing or risk factor profile deteriorating, is recommended.Reports of type 2 diabetes before age 10 years exist, and this can be considered with numerous risk factors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
50% to 60% of participants treated with tirzepatide 15 mg achieved normoglycemia (glycated hemoglobin below 39 mmol/mol [5.7%]).
“Notably, 50% to 60% of partici pants treated with tirzepatide 15 mg achieved normoglycemia (glycated hemoglobin values below 39 mmol/mol [5.7%]) (13), as defined by the American Diabetes Association (14).”
From Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test (2024) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited by
Sorted by citations
Oparil, S., Acelajado, M. C., Bakris, G. L., Berlowitz, D. R., Cífková, R., Dominiczak, A. F., Grassi, G., Jordan, J., Poulter, N. R., Rodgers, A., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.14 · Cited by 1,167 · see citing works
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Aronne, L. J., Horn, D. B., le Roux, C. W., Ho, W., Falcon, B. L., Gomez Valderas, E., Das, S., Lee, C. J., Glass, L. C., Senyucel, C., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2416394 · Cited by 634 · see citing works
Bednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148 · see citing works
Yang, Q., Bee, Y. M., Lim, C. C., Sabanayagam, C., Yim-Lui Cheung, C., Wong, T. Y., Ting, D. S. W., Lim, L.-L., Li, H., He, M., et al. (2025) · eClinicalMedicine · doi:10.1016/j.eclinm.2025.103089 · Cited by 38 · see citing works
Mather, K. J., Mari, A., Heise, T., DeVries, J. H., Hua, M., Urva, S., Coskun, T., Haupt, A., Heine, R. J., Pratt, E., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae319 · Cited by 32 · see citing works
Time to Treatment Intensification to Reduce Diabetes-Related Complications: A Post Hoc Study
Kaewbut, P., Kosachunhanun, N., Phrommintikul, A., Chinwong, D., Hall, J. J., & Chinwong, S. (2022) · Healthcare · doi:10.3390/healthcare10091673 · Cited by 11 · see citing works
Waqas, S. A., Ali, D., Afridi, M. K., Siddiqui, H. F., Nazir, A., Greene, S. J., & Khan, M. S. (2025) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2025.105981 · Cited by 11 · see citing works
Giorgino, F., Guerci, B., Füchtenbusch, M., Lebrec, J., Boye, K., Orsini Federici, M., Heitmann, E., Dib, A., Yu, M., Sapin, H., et al. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15244 · Cited by 7 · see citing works
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2022-01-01
- Volume
- 40
- Issue
- 1
- Pages
- 10-38
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- PMC
- PMC8865785
- OpenAlex
- W4200511306
- Cited by
- 664
- References
- 0
- Citations by year
- 2026: 72 · 2025: 122 · 2024: 180 · 2023: 192 · 2022: 94 · 2020: 1 · 2018: 1 · 2014: 1
- FWCI
- 87.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Touro Scholar (Touro College) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes care standards, primary care, evidence-based recommendations, type 2 diabetes, type 1 diabetes, diabetes diagnosis, diabetes treatment, glycemic control, diabetes screening, pediatric diabetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review